Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

ECM changes may play a role in hair loss, with differences between males and females.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Different ethnic groups have unique hair growth patterns, with African hair growing slower and less dense, Asian hair growing fast but sparse, and Caucasian hair being densest; men are more likely to experience hair loss than women.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

The MDhair app accurately assesses hair loss severity with 94% accuracy.

Trichoscopy is useful for detecting and monitoring androgenetic alopecia.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

The new hair loss treatment kit was safe and improved hair growth without any adverse effects.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

A new method using visual aids to diagnose hair diseases was effective after brief training.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Some treatments like minoxidil, finasteride, and dutasteride are effective for hair loss, but there's no agreed best treatment.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Placenta products might help with hair loss, but more research is needed.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.